Becton, Dickinson and Company (BDX) Fair Value 2026

BDX · Medical Instruments & Supplies ·

By CirclFi Research Team · Data from SEC EDGAR, FRED & GDELT

Quality Score

8.3 /10

32 fundamental signals · 11 models active

Value Trap Risk

SAFE (12/100)

Quick Summary — As of 2026-08-28, Becton, Dickinson and Company (BDX) trades at $189.52, versus a $190.45 median fair value across its 11 active models — 0.5% above the current price. QOC: 8.3/10. Value Trap Risk: 12/100 (SAFE). 11/13 models active. Within that set, the Bayesian DCF component alone returns $376.17.

Key Facts

Ticker
BDX
Price
$189.52
Quality Score
8.3/10
Value Trap Risk
12/100
Models Active
11/13
Last Updated
Strength: Bayesian DCF suggests +98.5% upside with 73% confidence
Risk: Limited model coverage (11/13) may reduce confidence

Is Becton, Dickinson and Company (BDX) Undervalued or Overvalued in 2026?

According to CirclFi’s 11-model valuation engine, Becton, Dickinson and Company (BDX) appears fairly valued as of : the median of 11 independent fair value estimates is $190.45, essentially in line with the current price of $189.52. Estimates range from $63.98 to $463.19. BDX scores 8.3/10 on fundamental quality and 12/100 on value-trap risk.

For context, the median US equity CirclFi rates trades at an implied -23.4% versus its own 13-model consensus, across 3,809 rated companies as of 2026-08-28. BDX’s +0.5% gap is narrower than that market norm, and the Medical Instruments & Supplies sector median is -29.3%. Full market index →

This verdict compares price to intrinsic value only — it is not a buy or sell rating. For the decision case (bull vs bear arguments, risk factors, peers), read Should You Buy Becton, Dickinson and Company Stock in 2026? →

What Fair Value Does Each Model Give BDX?

11 Intrinsic Value Models vs. Current Price ($189.52)

Core Models (Unlocked)
Model Fair Value Upside
Intrinsic · High Conviction
 $376.17 +98.5%
Intrinsic · High Conviction
 $63.98 -66.2%
Ensemble · Medium Conviction
 $190.45 +0.5%
Intrinsic · High Conviction
 $105.03 -44.6%
Unlock the Full Matrix

Access 7 additional models including Markov DDM, ML-RIV, and more.

$1.30 / day

Billed monthly ($39/mo) or annually ($299/yr)

Unlock All 11 Models →

Cancel anytime · No contracts · Instant access

What Is BDX's Fair Value Range?

Spread across 11 independent models · $63.98 to $463.19

CirclFi's 11 active models place Becton, Dickinson and Company (BDX) between $63.98 and $463.19 per share, a spread of 210% of the median. The median of that range — $190.45 — is the fair value CirclFi publishes for BDX, against a current price of $189.52.

Low · EPVHigh · Regime Cross
$63.98median $190.45$463.19
Where the range comes from
Most bearish modelEarnings Power Value (EPV)$63.98
Most bullish modelRegime Cross-Sectional$463.19
Model agreement5 bullish · 5 bearishwide

A band this wide is itself the finding. When independent methods land far apart, they are reading a business whose value depends heavily on which lens you apply — volatile earnings, heavy reinvestment, or an asset base that cash-flow and asset-based methods score differently. That disagreement is information: it says the choice of method matters more than usual for BDX. Treat the median as one reading among several and compare the individual models below before acting.

Every figure above is one model's standalone output on BDX, not a CirclFi price target. How each model works →

What Is Becton, Dickinson and Company (BDX) Worth in 2026?

According to the CirclFi Deep Alpha Valuation Engine, Becton, Dickinson and Company's intrinsic value is estimated at a median $190.45, showing conflicting signals at the current price of $189.52. While the median implied return is +0.5%, model disagreement is elevated with a gap of +210.6% between the most bullish and bearish estimates. The most optimistic model, Regime Cross, places fair value at $463.19 (+144.4%), while EPV — the most conservative — estimates $63.98 (-66.2%). This +210.6% gap reflects genuine analytical uncertainty about Becton, Dickinson and Company's intrinsic worth. Among models with highest confidence, Bayesian DCF, EPV lean bearish — adding weight to the bearish side of the thesis.

What Do the Models Say About BDX?

11 of 13 models are currently active for BDX. Of these, 6 models suggest upside while 5 models suggest overvaluation. Taken together, their median fair value for BDX is $190.45 — the figure CirclFi publishes as this stock's fair value. One component of that median, the Bayesian DCF, returns $376.17 on its own, implying +98.5% upside from the current price. See which stocks rank higher →

How Does BDX Rank in Medical Instruments & Supplies?

Among 56 Medical Instruments & Supplies stocks, BDX ranks #10 by Quality of Company score. CirclFi's QOC score of 8.3/10 evaluates 32 fundamental signals. A score of 8.3 places BDX in the top tier.

See all Most Undervalued Medical Instruments & Supplies Stocks →

Becton, Dickinson and Company operates in a competitive landscape where fundamental quality metrics are key differentiators for long-term value creation.

Is BDX a Value Trap?

CirclFi's Value Trap algorithm assigns BDX a score of 12/100 (SAFE). This indicates minimal risk. Fundamentals are healthy. The score cross-references apparent undervaluation against fundamental deterioration signals. Browse lowest value-trap stocks →

Multi-Model Methodology

11 of 13 models are active for Becton, Dickinson and Company. Broad coverage provides high confidence. Each model applies a fundamentally different valuation philosophy. See the complete methodology →

According to the CirclFi Deep Alpha Valuation Engine, Becton, Dickinson and Company scores 8.3 out of 10 on our 32-signal quality assessment, a strong rating that demonstrates strong fundamentals across the majority of our quality signals. The QOC score synthesizes profitability margins, revenue growth reliability, debt management, and capital allocation into a single metric designed to separate durable businesses from statistically cheap ones.

The gap between the most bullish and bearish model spans +210.6% — demonstrating why single-model analysis is dangerous. Browse all stocks with 13-model coverage →

Data Sources & Confidence

Every BDX valuation is built from SEC EDGAR XBRL filings — 700+ standardized financial tags. Macroeconomic context from FRED calibrates discount rates, while GDELT news sentiment feeds into our Sentiment SOTP model. All pipelines run daily. Read the complete data methodology →

Across BDX's 11 active models, average confidence is 55%. Moderate confidence indicates reasonable fit.

CirclFi's output is a research starting point, not a buy/sell signal. All data updates daily. Read the full methodology →

This analysis is produced by the CirclFi Valuation Engine using quantitative models applied to SEC EDGAR filings, public market feeds, and FRED macroeconomic indicators. It is not financial advice.

Read the full investment analysis: Should You Buy Becton, Dickinson and Company Stock in 2026? →

Bull case, bear case, risk factors & peer comparison — updated daily

Which Similar Medical Instruments & Supplies Stocks Should You Also Analyze?

11 related Medical Instruments & Supplies stocks with 13-model coverage

ALGNAlign Technology, Inc.QOC 8.4NVSTEnvista Holdings CorporationQOC 8.3NEPHNephros, Inc.QOC 8.4UTMDUtah Medical Products, Inc.QOC 8.2COOThe Cooper Companies, Inc.QOC 8.5RGENRepligen CorporationQOC 8.0NXGLNEXGEL, Inc.QOC 7.0XRAYDENTSPLY SIRONA Inc.QOC 6.1UEECUnited Health Products, Inc.QOC 4.1ISRGIntuitive Surgical, Inc.QOC 9.4RMDResMed Inc.QOC 9.4

Read investment analysis: ALGN · NVST · NEPH · UTMD · COO · RGEN · NXGL · XRAY · UEEC · ISRG · RMD

Which Other Stocks Have a Similar Quality Score to BDX?

7 companies across all industries closest to BDX’s Quality of Company score of 8.3/10.

TDCTeradata CorporationQOC 8.3VTEXVTEXQOC 8.3LIFLife360, Inc.QOC 8.3NKENIKE, Inc.QOC 8.3ALABAstera Labs, Inc.QOC 8.3SPGSimon Property Group, Inc.QOC 8.3NVDANVIDIA CorporationQOC 10.0

Read investment analysis: TDC · VTEX · LIF · NKE · ALAB · SPG · NVDA

Where Does BDX Sit in CirclFi's Medical Instruments & Supplies Rankings?

BDX is ranked against every other Medical Instruments & Supplies stock CirclFi covers in each of these screens.

See all Medical Instruments & Supplies stocks ranked →

What Else Do Investors Ask About Becton, Dickinson and Company’s Valuation?

What is Becton, Dickinson and Company's intrinsic value in 2026?

CirclFi puts Becton, Dickinson and Company (BDX)'s intrinsic value at $190.45 — the median of 11 independent model estimates as of 2026-08-28, ranging from $63.98 to $463.19. One component of that median, the Bayesian DCF, runs 10,000 Monte Carlo simulations with jump-diffusion and returns $376.17 on its own. The Quality of Company score is 8.3/10 across 32 fundamental signals. All models use SEC EDGAR filings updated daily. See our methodology page for how each model works.

Is BDX overvalued or undervalued right now?

At $189.52, 6 of 11 active models suggest BDX may be undervalued, while 5 indicate potential overvaluation. The median of all 11 fair value estimates is $190.45, essentially in line with the current price of $189.52 — a consensus view that BDX is fairly valued. The assessment depends on which methodology best fits Becton, Dickinson and Company's business model in Medical Instruments & Supplies.

What does a Quality of Company score of 8.3 mean for BDX?

Becton, Dickinson and Company's QOC of 8.3/10 reflects 32 fundamental signals: profitability margins, revenue growth consistency, balance sheet leverage, free cash flow generation, and capital allocation efficiency. Scores above 7 indicate strong fundamentals and disciplined management.

How many valuation models does CirclFi run on BDX?

CirclFi analyzes BDX with 13 institutional-grade models daily: Bayesian DCF (Monte Carlo + jump-diffusion), EPV (Greenwald zero-growth), EROIC Spread (McKinsey reinvestment), First Chicago (3-scenario), Markov DDM (regime-switching), ML-RIV (machine learning residual income), Dynamic NAV (asset-based), PWERM (option-theoretic), Regime Cross-Sectional (relative), Sentiment SOTP (hybrid), CUCE Ensemble (meta-model), FTNN Topology (neural network), and RCMH-DCF (conditional regime). Currently 11 of 13 are active for this stock. Read the full methodology →

Which valuation models are most bullish and most bearish on BDX?

Of the 11 models currently active on BDX, Regime Cross-Sectional is the most bullish at $463.19 per share, and Earnings Power Value (EPV) is the most bearish at $63.98. CirclFi's published fair value for BDX is the median of that range, $190.45, not either extreme. The gap between the two ends equals 210% of the median — a wide spread, meaning the methods genuinely disagree and the median should carry less weight. Browse stocks by value-trap risk →

Is BDX a value trap in 2026?

Becton, Dickinson and Company's Value Trap score is 12/100 (SAFE). This low score indicates the current valuation is not artificially depressed by fundamental deterioration, suggesting genuine opportunity rather than a trap.

Cite this analysis — “According to CirclFi’s 11-model valuation engine, Becton, Dickinson and Company (BDX) has a median fair value of $190.45 — essentially in line with the current price of $189.52 — as of 2026-08-28.” Source: circlfi.com/stock/BDX/ · Methodology
Primary sources for this BDX valuation
  • Financial statements: Becton, Dickinson and Company 10-K and 10-Q filings on SEC EDGAR (CIK 0000010795) — 700+ standardized XBRL tags, published by the U.S. Securities and Exchange Commission.
  • Discount-rate inputs: FRED, Federal Reserve Bank of St. Louis — risk-free rates, VIX, yield curve, inflation.
  • News sentiment: The GDELT Project — global media tone, input to the Sentiment SOTP model.
  • Model definitions: CirclFi methodology — the published specification for all 13 models, including the academic sources each one implements.

Market data for BDX as of ; valuations recomputed .

You’ve done the research. Don’t stop at half the picture.

Stop collecting opinions. Let 11 mathematical frameworks give you clarity on BDX.

Unlock All 11 Fair Values — $39/mo

Cancel anytime · Less than a cup of coffee · Instant access

7 models hidden for BDX Unlock All 11 — $39/mo